Holen Sie sich die Stockscreener-App
0.73
6.12%
0.0421
Schlusskurs vom Vortag:
$0.6879
Offen:
$0.73
24-Stunden-Volumen:
23,263
Relative Volume:
0.01
Marktkapitalisierung:
$4.31M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-3.72%
1M Leistung:
-14.12%
6M Leistung:
-99.86%
1J Leistung:
+0.00%
1-Tages-Spanne:
$0.73
$0.73
1-Wochen-Bereich:
$0.663
$0.76
52-Wochen-Spanne:
$0.55
$1,200.00
Polyrizon Ltd Stock (PLRZ) Company Profile
Vergleichen Sie PLRZ mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PLRZ
Polyrizon Ltd
|
0.73 | 4.31M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
447.17 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
518.58 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
322.94 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
558.79 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
264.99 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Polyrizon Ltd Aktie (PLRZ) Neueste Nachrichten
Polyrizon Ltd Inc. (PLRZ) Price Performance: How to Use Technical Analysis to Make Trading Decisions - investchronicle.com
Polyrizon’s nasal drug delivery system shows promising results By Investing.com - Investing.com South Africa
Polyrizon Reports Promising Results Demonstrating Successful Internasal Delivery of its Innovative Hydrogel Formulation for CNS Therapeutics - MarketScreener
Polyrizon’s nasal drug delivery system shows promising results - Investing.com Australia
Polyrizon Announces Promising Preclinical Results for CNS Therapeutics - TipRanks
Revolutionary Nasal Drug Delivery System Could Transform Treatment of Opioid Overdose and Epilepsy - Stock Titan
Smart Digital Group And Polyrizon See Unusual Market Moves - Finimize
Polyrizon Ltd. Announces Reverse Share Split Effective May 27, 2025 - TipRanks
Polyrizon recives Nasdaq delisting notice - MSN
Polyrizon faces Nasdaq delisting over shareholder dilution By Investing.com - Investing.com India
Polyrizon Stock Price, Quotes and Forecasts | NASDAQ:PLRZ - Benzinga
Polyrizon faces Nasdaq delisting over shareholder dilution - Investing.com Australia
Polyrizon Receives Nasdaq Delisting Notice Amid Shareholder Concerns - TipRanks
Polyrizon Receives Nasdaq Delisting Notice - marketscreener.com
Polyrizon receives noncompliance letter from Nasdaq - TipRanks
Polyrizon Announces Receipt of Nasdaq Delisting Notice - The Manila Times
Polyrizon announces preclinical data on nasal protection platform - TipRanks
Polyrizon Emerges with Positive Preclinical Data on Nasal Protection Platform - Bluefield Daily Telegraph
Revolutionary Nasal Drug Delivery Platform Achieves Perfect Coverage Score in Latest Tests - Stock Titan
Pennies on the Rise: HCTI, SWISF, ADHC, NCNA Gain Traction Amid LargeCap Uncertainty – More Stocks Inside - FinancialContent
Polyrizon Ltd. Increases Outstanding Shares Following Warrant Exercises - TipRanks
Polyrizon Ltd. Announces Increase in Outstanding Shares Following Warrant Exercises - TipRanks
Nasdaq Gains Over 100 Points; Sony Group Posts Upbeat Earnings - Benzinga
Nasdaq Rises Over 1%; Under Armour Posts Strong Q4 Sales - Benzinga
Polyrizon begins preclinical studies for seizure treatment - Investing.com Australia
Polyrizon announces initiation of preclinical studies for Benzodiazepines - TipRanks
Polyrizon Targets $3.15B Epilepsy Market with Preclinical Studies for Innovative Rescue Treatment - The Manila Times
Polyrizon begins preclinical studies for seizure treatment By Investing.com - Investing.com Nigeria
Why Coinbase Global Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket - Benzinga
Polyrizon, Pheton, AirSculpt: Top 3 Healthcare Stocks With Soaring Weekly Retail Interest - MSN
Promising Small Cap Stocks To Follow NowMay 4th - MarketBeat
Best Small Cap Stocks To ConsiderMay 3rd - MarketBeat
Polyrizon Ltd. Announces 1-for-10 Reverse Share Split Effective May 5, 2025 - TipRanks
US Stocks Likely To Open Lower After S&P 500's 9-Day Streak: 'Any De-Escalation In Trade Tensions Should Be Positive,' Says Expert - Benzinga
Why Faraday Future Intelligent Electric Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket - Benzinga
Polyrizon, Pheton, AirSculpt: Top 3 Healthcare Stocks With Soaring Weekly Retail Interest By Stocktwits - Investing.com India
Upcoming Stock Splits This Week (May 5 to May 9) – Stay Invested - TipRanks
PLRZPolyrizon Ltd Latest Stock News & Market Updates - Stock Titan
Promising Biotech Stocks To Watch Today – May 2nd - Defense World
United States shares higher at close of trade; Dow Jones Industrial Average up 1.39% - Investing.com India
Nasdaq Surges Over 300 Points; Apple Shares Fall After Q2 Results - Benzinga
PLRZ Stock: Exploring Polyrizon Ltd’s Growth - investchronicle.com
Polyrizon (PLRZ) Stock Skyrocketed Over 240% Today: What's Going On? - Benzinga
PLRZ’s price-to-cash ratio: How it affects the stock’s valuation. - uspostnews.com
Finanzdaten der Polyrizon Ltd-Aktie (PLRZ)
Es liegen keine Finanzdaten für Polyrizon Ltd (PLRZ) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.73%
1.27%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):